Download PDF
Ultraschall Med 2020; 41(05): 562-585
DOI: 10.1055/a-1177-0530
Guidelines & Recommendations

Guidelines and Good Clinical Practice Recommendations for Contrast Enhanced Ultrasound (CEUS) in the Liver – Update 2020 – WFUMB in Cooperation with EFSUMB, AFSUMB, AIUM, and FLAUS

Aktualisierte Leitlinien und Empfehlungen für die gute klinische Praxis für CEUS der Leber
Christoph F. Dietrich   *
1   Department Allgemeine Innere Medizin (DAIM), Kliniken Hirslanden Beau Site, Salem und Permanence, Bern, Switzerland
2   Johann Wolfgang Goethe Universitätsklinik Frankfurt, Germany
,
Christian Pállson Nolsøe   *
3   Center for Surgical Ultrasound, Dep of Surgery, Zealand University Hospital, Køge. Copenhagen Academy for Medical Education and Simulation (CAMES). University of Copenhagen, Denmark
,
Richard G. Barr
4   Department of Radiology, Northeastern Ohio Medical University, Rootstown, Ohio, USA and Southwoods Imaging, Youngstown, Ohio, USA
,
Annalisa Berzigotti
5   Hepatology, University Clinic for Visceral Surgery and Medicine, DBMR, Inselspital, University of Bern, Switzerland
,
Peter N Burns
6   Dept Medical Biophysics, University of Toronto, Imaging Research, Sunnybrook Research Institute, Toronto
,
Vito Cantisani
7   Uos Ecografia Internistico-chirurgica, Dipartimento di Scienze Radiologiche, Oncologiche, Anatomo-Patologiche, Policlinico Umberto I, Univ. Sapienza, Rome, Italy
,
Maria Cristina Chammas
8   Institute of Radiology, Hospital das Clínicas, School of Medicine, University of São Paulo, Brazil
,
Nitin Chaubal
9   Thane Ultrasound Centre, Jaslok Hospital and Research Centre, Mumbai, India
,
Byung Ihn Choi
10   Department of Radiology, Chung-Ang University Hospital, Seoul, Korea
,
Dirk-André Clevert
11   Interdisciplinary Ultrasound-Center, Department of Radiology, University of Munich-Grosshadern Campus, Munich, Germany
,
Xinwu Cui
12   Department of Medical Ultrasound, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan China
,
Yi Dong
13   Department of Ultrasound, Zhongshan Hospital, Fudan University, Shanghai, China
,
Mirko D’Onofrio
14   Department of Radiology, G.B. Rossi University Hospital, University of Verona, Verona, Italy
,
J. Brian Fowlkes
15   Basic Radiological Sciences Division, Department of Radiology, University of Michigan Health System, Ann Arbor, MI, United States
,
Odd Helge Gilja
16   National Centre for Ultrasound in Gastroenterology, Haukeland University Hospital, Bergen, and Department of Clinical Medicine, University of Bergen, Norway
,
Pintong Huang
17   Department of Ultrasound in Medicine, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
,
Andre Ignee
18   Department of Internal Medicine 2, Caritas Krankenhaus, Bad Mergentheim, Germany
,
Christian Jenssen
19   Krankenhaus Märkisch Oderland, Department of Internal Medicine, Strausberg/Wriezen, Germany
,
Yuko Kono
20   Departments of Medicine and Radiology, University of California, San Diego, USA
,
Masatoshi Kudo
21   Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Osaka, Japan
,
Nathalie Lassau
22   Imaging Department. Gustave Roussy and BIOMAPS. Université Paris-Saclay, Villejuif, France
,
Won Jae Lee
23   Department of Radiology and Center For Imaging Science, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. Departments of Health and Science and Technology and Medical Device Management and Research, Samsung Advanced Institute for Health Science and Technology, Sungkyunkwan University, Seoul, Korea
,
Jae Young Lee
24   Department of Radiology, Seoul National University College of Medicine, Seoul, Korea
,
Ping Liang
25   Department of Interventional Ultrasound, Chinese PLA General Hospital, Beijing, China
,
Adrian Lim
26   Department of Imaging, Imperial College London and Healthcare NHS Trust, Charing Cross Hospital Campus, London United Kingdom
,
Andrej Lyshchik
27   Department of Radiology, Thomas Jefferson University Hospital, Philadelphia, PA, United States
,
Maria Franca Meloni
28   Radiology Dept, University of Pavia, Milano, Italy
,
Jean Michel Correas
29   Service de Radiologie Adultes, Hôpital Necker, Université Paris Descartes, Paris, France
,
Yasunori Minami
30   Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Osaka, Japan
,
Fuminori Moriyasu
31   Center for Cancer Ablation Therapy, Sanno Hospital, International University of Health and Welfare, Tokyo, Japan
,
Carlos Nicolau
32   Radiology Department, Hospital Clinic. University of Barcelona, Barcelona, Spain
,
Fabio Piscaglia
33   Unit of Internal Medicine, Dept of Medical and Surgical Sciences, University of Bologna S. Orsola-Malpighi Hospital, Bologna, Italy
,
Adrian Saftoiu
34   Research Center of Gastroenterology and Hepatology Craiova, University of Medicine and Pharmacy Craiova, Romania
,
Paul S. Sidhu
35   Department of Radiology, King’s College Hospital, King’s College London, London
,
Ioan Sporea
36   Department of Gastroenterology and Hepatology, University of Medicine and Pharmacy “Victor Babes”, Timisoara, Romania
,
Guido Torzilli
37   Department of Surgery, Division of Hepatobiliary & General Surgery, Humanitas University & Research Hospital, Rozzano, Milano, Italy
,
Xiaoyan Xie
38   Department of Medical Ultrasonics, Institute of Diagnostic and Interventional Ultrasound, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China
,
Rongqin Zheng
39   Department of Ultrasound, The 3rd Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
› Author Affiliations
› Further Information
Also available at
   Permissions and Reprints

Abstract

The present, updated document describes the fourth iteration of recommendations for the hepatic use of contrast enhanced ultrasound (CEUS), first initiated in 2004 by the European Federation of Societies for Ultrasound in Medicine and Biology (EFSUMB). The previous updated editions of the guidelines reflected changes in the available contrast agents and updated the guidelines not only for hepatic but also for non-hepatic applications.

The 2012 guideline requires updating as previously the differences of the contrast agents were not precisely described and the differences in contrast phases as well as handling were not clearly indicated. In addition, more evidence has been published for all contrast agents. The update also reflects the most recent developments in contrast agents, including the United States Food and Drug Administration (FDA) approval as well as the extensive Asian experience, to produce a truly international perspective.

These guidelines and recommendations provide general advice on the use of ultrasound contrast agents (UCA) and are intended to create standard protocols for the use and administration of UCA in liver applications on an international basis to improve the management of patients.

Key words

contrast enhanced ultrasound (CEUS) - World Federation for Ultrasound in Medicine and Biology (WFUMB) - guideline - liver

* Co-first authors.




Publication History

Received: 30 April 2020

Accepted: 12 May 2020

Article published online:
24 July 2020

© 2020. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Albrecht T, Blomley M, Bolondi L. et al. Guidelines for the use of contrast agents in ultrasound. January 2004. Ultraschall in Med 2004; 25: 249-256
    Thieme ConnectPubMedSearch in Google Scholar
  • 2 Claudon M, Dietrich CF, Choi BI. et al. Guidelines and Good Clinical Practice Recommendations for Contrast Enhanced Ultrasound (CEUS) in the Liver – Update 2012. Ultraschall in Med 2013; 34: 11-29
    Thieme ConnectPubMedSearch in Google Scholar
  • 3 Claudon M, Dietrich CF, Choi BI. et al. Guidelines and good clinical practice recommendations for Contrast Enhanced Ultrasound (CEUS) in the liver – update 2012: A WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultrasound Med Biol 2013; 39: 187-210
    CrossrefPubMedSearch in Google Scholar
  • 4 Sidhu PS, Cantisani V, Dietrich CF. et al. The EFSUMB Guidelines and Recommendations for the Clinical Practice of Contrast-Enhanced Ultrasound (CEUS) in Non-Hepatic Applications: Update 2017 (Short Version). Ultraschall in Med 2018; 39: 154-180
    Thieme ConnectPubMedSearch in Google Scholar
  • 5 Sidhu PS, Cantisani V, Dietrich CF. et al. The EFSUMB Guidelines and Recommendations for the Clinical Practice of Contrast-Enhanced Ultrasound (CEUS) in Non-Hepatic Applications: Update 2017 (Long Version). Ultraschall in Med 2018; 39: e2-e44
    Thieme ConnectPubMedSearch in Google Scholar
  • 6 Jenssen C, Gilja OH, Serra AL. et al. European Federation of Societies for Ultrasound in Medicine and Biology (EFSUMB) Policy Document Development Strategy – Clinical Practice Guidelines, Position Statements and Technological Reviews. Ultrasound Int Open 2019; 5: E2-E10
    Thieme ConnectPubMedSearch in Google Scholar
  • 7 Piscaglia F, Bolondi L. The safety of Sonovue in abdominal applications: retrospective analysis of 23188 investigations. Ultrasound Med Biol 2006; 32: 1369-1375
    CrossrefPubMedSearch in Google Scholar
  • 8 Main ML, Goldman JH, Grayburn PA. Thinking outside the “box”-the ultrasound contrast controversy. J Am Coll Cardiol 2007; 50: 2434-2437
    CrossrefPubMedSearch in Google Scholar
  • 9 Main ML, Goldman JH, Grayburn PA. Ultrasound contrast agents: balancing safety versus efficacy. Expert Opin Drug Saf 2009; 8: 49-56
    CrossrefPubMedSearch in Google Scholar
  • 10 Dietrich CF, Bamber J, Berzigotti A. et al. EFSUMB Guidelines and Recommendations on the Clinical Use of Liver Ultrasound Elastography, Update 2017 (Short Version). Ultraschall in Med 2017; 38: 377-394
    Thieme ConnectPubMedSearch in Google Scholar
  • 11 Tang C, Fang K, Guo Y. et al. Safety of Sulfur Hexafluoride Microbubbles in Sonography of Abdominal and Superficial Organs: Retrospective Analysis of 30222 Cases. J Ultrasound Med 2017; 36: 531-538
    CrossrefPubMedSearch in Google Scholar
  • 12 Kitzman DW, Goldman ME, Gillam LD. et al. Efficacy and safety of the novel ultrasound contrast agent perflutren (definity) in patients with suboptimal baseline left ventricular echocardiographic images. Am J Cardiol 2000; 86: 669-674
    CrossrefPubMedSearch in Google Scholar
  • 13 Wilson SR, Burns PN. Microbubble-enhanced US in body imaging: what role?. Radiology 2010; 257: 24-39
    CrossrefPubMedSearch in Google Scholar
  • 14 Cochran ST, Bomyea K, Sayre JW. Trends in adverse events after IV administration of contrast media. Am J Roentgenol 2001; 176: 1385-1388
    CrossrefPubMedSearch in Google Scholar
  • 15 Hunt CH, Hartman RP, Hesley GK. Frequency and severity of adverse effects of iodinated and gadolinium contrast materials: retrospective review of 456930 doses. Am J Roentgenol 2009; 193: 1124-1127
    CrossrefPubMedSearch in Google Scholar
  • 16 CHMP. Committee for Medicinal Products for Human Use (CHMP) Assessment report EMA/84084/2014. SonoVue. international non-properietary name: sulfur hexafluoride. 2014
    PubMedSearch in Google Scholar
  • 17 Darge K, Papadopoulou F, Ntoulia A. et al. Safety of contrast-enhanced ultrasound in children for non-cardiac applications: a review by the Society for Pediatric Radiology (SPR) and the International Contrast Ultrasound Society (ICUS). Pediatr Radiol 2013; 43: 1063-1073
    CrossrefPubMedSearch in Google Scholar
  • 18 Papadopoulou F, Ntoulia A, Siomou E. et al. Contrast-enhanced voiding urosonography with intravesical administration of a second-generation ultrasound contrast agent for diagnosis of vesicoureteral reflux: prospective evaluation of contrast safety in 1010 children. Pediatr Radiol 2014; 44: 719-728
    CrossrefPubMedSearch in Google Scholar
  • 19 Sidhu PS, Cantisani V, Deganello A. et al. Role of Contrast-Enhanced Ultrasound (CEUS) in Paediatric Practice: An EFSUMB Position Statement. Ultraschall in Med 2017; 38: 33-43
    Thieme ConnectPubMedSearch in Google Scholar
  • 20 Sidhu PS, Cantisani V, Deganello A. et al. Authors’ Reply to Letter: Role of Contrast-Enhanced Ultrasound (CEUS) in Paediatric Practice: An EFSUMB Position Statement. Ultraschall in Med 2017; 38: 447-448
    Thieme ConnectPubMedSearch in Google Scholar
  • 21 Sellars ME, Deganello A, Sidhu PS. Paediatric contrast-enhanced ultrasound (CEUS): a technique that requires co-operation for rapid implementation into clinical practice. Ultraschall in Med 2014; 35: 203-206
    Thieme ConnectPubMedSearch in Google Scholar
  • 22 Schwarze V, Marschner C, Negrao de Figueiredo G. et al. Single-Center Study: Evaluating the Diagnostic Performance and Safety of Contrast-Enhanced Ultrasound (CEUS) in Pregnant Women to Assess Hepatic Lesions. Ultraschall in Med 2020; 41: 29-35
    Thieme ConnectPubMedSearch in Google Scholar
  • 23 Dietrich CF, Averkiou M, Nielsen MB. et al. How to perform Contrast-Enhanced Ultrasound (CEUS). Ultrasound Int Open 2018; 4: E2-E15
    Thieme ConnectPubMedSearch in Google Scholar
  • 24 Wilson SR, Kim TK, Jang HJ. et al. Enhancement patterns of focal liver masses: discordance between contrast-enhanced sonography and contrast-enhanced CT and MRI. Am J Roentgenol 2007; 189: W7-W12
    CrossrefPubMedSearch in Google Scholar
  • 25 D’Onofrio M, Crosara S, De Robertis R. et al. Contrast-Enhanced Ultrasound of Focal Liver Lesions. Am J Roentgenol 2015; 205: W56-W66
    CrossrefPubMedSearch in Google Scholar
  • 26 Rossi S, Ghittoni G, Ravetta V. et al. Contrast-enhanced ultrasonography and spiral computed tomography in the detection and characterization of portal vein thrombosis complicating hepatocellular carcinoma. Eur Radiol 2008; 18: 1749-1756
    CrossrefPubMedSearch in Google Scholar
  • 27 Faccioli N, D’Onofrio M, Comai A. et al. Contrast-enhanced ultrasonography in the characterization of benign focal liver lesions: activity-based cost analysis. Radiol Med 2007; 112: 810-820
    CrossrefPubMedSearch in Google Scholar
  • 28 Quaia E, Calliada F, Bertolotto M. et al. Comparison of diagnostic performance of unenhanced vs SonoVue – enhanced ultrasonography in focal liver lesions characterization. The experience of three Italian centers. Radiol Med (Torino) 2004; 108: 71-81
    PubMedSearch in Google Scholar
  • 29 Trillaud H, Bruel JM, Valette PJ. et al. Characterization of focal liver lesions with SonoVue-enhanced sonography: international multicenter-study in comparison to CT and MRI. World J Gastroenterol 2009; 15: 3748-3756
    CrossrefPubMedSearch in Google Scholar
  • 30 Friedrich-Rust M, Klopffleisch T, Nierhoff J. et al. Contrast-Enhanced Ultrasound for the differentiation of benign and malignant focal liver lesions: a meta-analysis. Liver Int 2013; 33: 739-755
    CrossrefPubMedSearch in Google Scholar
  • 31 D’Onofrio M, Crosara S, De Robertis R. et al. Malignant focal liver lesions at contrast-enhanced ultrasonography and magnetic resonance with hepatospecific contrast agent. Ultrasound 2014; 22: 91-98
    CrossrefPubMedSearch in Google Scholar
  • 32 Barr RG. Contrast enhanced ultrasound for focal liver lesions: how accurate is it?. Abdom Radiol (NY) 2018; 43: 1128-1133
    CrossrefPubMedSearch in Google Scholar
  • 33 Seitz K, Strobel D, Bernatik T. et al. Contrast-Enhanced Ultrasound (CEUS) for the characterization of focal liver lesions – prospective comparison in clinical practice: CEUS vs. CT (DEGUM multicenter trial). Parts of this manuscript were presented at the Ultrasound Dreilandertreffen 2008, Davos. Ultraschall in Med 2009; 30: 383-389
    Thieme ConnectPubMedSearch in Google Scholar
  • 34 Burns PN, Wilson SR. Focal liver masses: enhancement patterns on contrast-enhanced images–concordance of US scans with CT scans and MR images. Radiology 2007; 242: 162-174
    CrossrefPubMedSearch in Google Scholar
  • 35 Laghi F, Catalano O, Maresca M. et al. Indeterminate, subcentimetric focal liver lesions in cancer patients: additional role of contrast-enhanced ultrasound. Ultraschall in Med 2010; 31: 283-288
    Thieme ConnectPubMedSearch in Google Scholar
  • 36 Parsai A, Miquel ME, Jan H. et al. Improving liver lesion characterisation using retrospective fusion of FDG PET/CT and MRI. Clin Imaging 2019; 55: 23-28
    CrossrefPubMedSearch in Google Scholar
  • 37 Jo PC, Jang HJ, Burns PN. et al. Integration of Contrast-enhanced US into a Multimodality Approach to Imaging of Nodules in a Cirrhotic Liver: How I Do It. Radiology 2017; 282: 317-331
    CrossrefPubMedSearch in Google Scholar
  • 38 Itabashi T, Sasaki A, Otsuka K. et al. Potential value of sonazoid-enhanced intraoperative laparoscopic ultrasonography for liver assessment during laparoscopy-assisted colectomy. Surg Today 2014; 44: 696-701
    CrossrefPubMedSearch in Google Scholar
  • 39 Muhi A, Ichikawa T, Motosugi U. et al. Diagnosis of colorectal hepatic metastases: comparison of contrast-enhanced CT, contrast-enhanced US, superparamagnetic iron oxide-enhanced MRI, and gadoxetic acid-enhanced MRI. J Magn Reson Imaging 2011; 34: 326-335
    CrossrefPubMedSearch in Google Scholar
  • 40 Cantisani V, Ricci P, Erturk M. et al. Detection of hepatic metastases from colorectal cancer: prospective evaluation of gray scale US versus SonoVue(R) low mechanical index real time-enhanced US as compared with multidetector-CT or Gd-BOPTA-MRI. Ultraschall in Med 2010; 31: 500-505
    Thieme ConnectPubMedSearch in Google Scholar
  • 41 Larsen LP, Rosenkilde M, Christensen H. et al. Can contrast-enhanced ultrasonography replace multidetector-computed tomography in the detection of liver metastases from colorectal cancer?. Eur J Radiol 2009; 69: 308-313
    CrossrefPubMedSearch in Google Scholar
  • 42 Piscaglia F, Corradi F, Mancini M. et al. Real time contrast enhanced ultrasonography in detection of liver metastases from gastrointestinal cancer. BMC Cancer 2007; 7: 171
    CrossrefPubMedSearch in Google Scholar
  • 43 Konopke R, Kersting S, Bergert H. et al. Contrast-enhanced ultrasonography to detect liver metastases: A prospective trial to compare transcutaneous unenhanced and contrast-enhanced ultrasonography in patients undergoing laparotomy. Int J Colorectal Dis 2007; 22: 201-207
    CrossrefPubMedSearch in Google Scholar
  • 44 Larsen LP, Rosenkilde M, Christensen H. et al. The value of contrast enhanced ultrasonography in detection of liver metastases from colorectal cancer: a prospective double-blinded study. Eur J Radiol 2007; 62: 302-307
    CrossrefPubMedSearch in Google Scholar
  • 45 Dietrich CF, Kratzer W, Strobe D. et al. Assessment of metastatic liver disease in patients with primary extrahepatic tumors by contrast-enhanced sonography versus CT and MRI. World J Gastroenterol 2006; 12: 1699-1705
    CrossrefPubMedSearch in Google Scholar
  • 46 Konopke R, Kersting S, Saeger HD. et al. Detection of liver lesions by contrast-enhanced ultrasound – comparison to intraoperative findings. Ultraschall in Med 2005; 26: 107-113
    Thieme ConnectPubMedSearch in Google Scholar
  • 47 Quaia E, D’Onofrio M, Palumbo A. et al. Comparison of contrast-enhanced ultrasonography versus baseline ultrasound and contrast-enhanced computed tomography in metastatic disease of the liver: diagnostic performance and confidence. Eur Radiol 2006; 16: 1599-1609
    CrossrefPubMedSearch in Google Scholar
  • 48 Larsen LP. Role of contrast enhanced ultrasonography in the assessment of hepatic metastases: A review. World J Hepatol 2010; 2: 8-15
    CrossrefPubMedSearch in Google Scholar
  • 49 Forner A, Vilana R, Ayuso C. et al. Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma. Hepatology 2008; 47: 97-104
    CrossrefPubMedSearch in Google Scholar
  • 50 Dong Y, Zhang XL, Mao F. et al. Contrast-enhanced ultrasound features of histologically proven small (</=20 mm) liver metastases. Scand J Gastroenterol 2017; 52: 23-28
    CrossrefPubMedSearch in Google Scholar
  • 51 Tang A, Bashir MR, Corwin MT. et al. Evidence Supporting LI-RADS Major Features for CT- and MR Imaging-based Diagnosis of Hepatocellular Carcinoma: A Systematic Review. Radiology 2018; 286: 29-48
    CrossrefPubMedSearch in Google Scholar
  • 52 Wilson SR, Lyshchik A, Piscaglia F. et al. CEUS LI-RADS: algorithm, implementation, and key differences from CT/MRI. Abdom Radiol (NY) 2018; 43: 127-142
    CrossrefPubMedSearch in Google Scholar
  • 53 Hatanaka K, Kudo M, Minami Y. et al. Sonazoid-enhanced ultrasonography for diagnosis of hepatic malignancies: comparison with contrast-enhanced CT. Oncology 2008; 75 (Suppl. 01) 42-47
    CrossrefPubMedSearch in Google Scholar
  • 54 Moriyasu F, Itoh K. Efficacy of perflubutane microbubble-enhanced ultrasound in the characterization and detection of focal liver lesions: phase 3 multicenter clinical trial. Am J Roentgenol 2009; 193: 86-95
    CrossrefPubMedSearch in Google Scholar
  • 55 Maruyama H, Takahashi M, Ishibashi H. et al. Ultrasound-guided treatments under low acoustic power contrast harmonic imaging for hepatocellular carcinomas undetected by B-mode ultrasonography. Liver Int 2009; 29: 708-714
    CrossrefPubMedSearch in Google Scholar
  • 56 Martie A, Bota S, Sporea I. et al. The contribution of contrast enhanced ultrasound for the characterization of benign liver lesions in clinical practice – a monocentric experience. Med Ultrason 2012; 14: 283-287
    PubMedSearch in Google Scholar
  • 57 Guang Y, Xie L, Ding H. et al. Diagnosis value of focal liver lesions with SonoVue(R)-enhanced ultrasound compared with contrast-enhanced computed tomography and contrast-enhanced MRI: a meta-analysis. J Cancer Res Clin Oncol 2011; 137: 1595-1605
    CrossrefPubMedSearch in Google Scholar
  • 58 Karhunen PJ. Benign hepatic tumours and tumour like conditions in men. J Clin Pathol 1986; 39: 183-188
    CrossrefPubMedSearch in Google Scholar
  • 59 Xu HX, Lu MD, Liu GJ. et al. Imaging of peripheral cholangiocarcinoma with low-mechanical index contrast-enhanced sonography and SonoVue: initial experience. J Ultrasound Med 2006; 25: 23-33
    CrossrefPubMedSearch in Google Scholar
  • 60 Linhart P, Bonhof JA, Baque PE. et al. Ultrasound in diagnosis of benign and malignant liver tumors. Zentralbl Chir 1998; 123: 119-123
    PubMedSearch in Google Scholar
  • 61 Hirche TO, Russler J, Schroder O. et al. The value of routinely performed ultrasonography in patients with Crohn disease. Scand J Gastroenterol 2002; 37: 1178-1183
    CrossrefPubMedSearch in Google Scholar
  • 62 Sandrose SW, Karstrup S, Gerke O. et al. Contrast Enhanced Ultrasound in CT-undetermined Focal Liver Lesions. Ultrasound Int Open 2016; 2: E129-E135
    PubMedSearch in Google Scholar
  • 63 Volk M, Strotzer M, Lenhart M. et al. Frequency of benign hepatic lesions incidentally detected with contrast-enhanced thin-section portal venous phase spiral CT. Acta Radiol 2001; 42: 172-175
    CrossrefPubMedSearch in Google Scholar
  • 64 Seitz K, Bernatik T, Strobel D. et al. Contrast-enhanced ultrasound (CEUS) for the characterization of focal liver lesions in clinical practice (DEGUM Multicenter Trial): CEUS vs. MRI–a prospective comparison in 269 patients. Ultraschall in Med 2010; 31: 492-499
    Thieme ConnectPubMedSearch in Google Scholar
  • 65 von Herbay A, Westendorff J, Gregor M. Contrast-enhanced ultrasound with SonoVue: differentiation between benign and malignant focal liver lesions in 317 patients. J Clin Ultrasound 2010; 38: 1-9
    PubMedSearch in Google Scholar
  • 66 Strobel D, Seitz K, Blank W. et al. Contrast-enhanced ultrasound for the characterization of focal liver lesions – diagnostic accuracy in clinical practice (DEGUM multicenter trial). Ultraschall in Med 2008; 29: 499-505
    Thieme ConnectPubMedSearch in Google Scholar
  • 67 Strobel D, Seitz K, Blank W. et al. Tumor-Specific Vascularization Pattern of Liver Metastasis, Hepatocellular Carcinoma, Hemangioma and Focal Nodular Hyperplasia in the Differential Diagnosis of 1349 Liver Lesions in Contrast-Enhanced Ultrasound (CEUS). Ultraschall in Med 2009; 30: 376-382
    Thieme ConnectPubMedSearch in Google Scholar
  • 68 Seitz K, Greis C, Schuler A. et al. Frequency of tumor entities among liver tumors of unclear etiology initially detected by sonography in the noncirrhotic or cirrhotic livers of 1349 patients. Results of the DEGUM multicenter study. Ultraschall in Med 2011; 32: 598-603
    Thieme ConnectPubMedSearch in Google Scholar
  • 69 Strobel D, Bernatik T, Blank W. et al. Diagnostic accuracy of CEUS in the differential diagnosis of small (</= 20 mm) and subcentimetric (</= 10 mm) focal liver lesions in comparison with histology. Results of the DEGUM multicenter trial. Ultraschall in Med 2011; 32: 593-597
    Thieme ConnectPubMedSearch in Google Scholar
  • 70 Bernatik T, Seitz K, Blank W. et al. Unclear focal liver lesions in contrast-enhanced ultrasonography – lessons to be learned from the DEGUM multicenter study for the characterization of liver tumors. Ultraschall in Med 2010; 31: 577-581
    Thieme ConnectPubMedSearch in Google Scholar
  • 71 Devine AS, Jackson CS, Lyons L. et al. Frequency of incidental findings on computed tomography of trauma patients. West J Emerg Med 2010; 11: 24-27
    PubMedSearch in Google Scholar
  • 72 Dietrich CF, Ignee A, Trojan J. et al. Improved characterization of histologically proven liver tumours by contrast enhanced ultrasonography during the portal venous and specific late phase of SHU 508A. GUT 2004; 53: 401-405
    CrossrefPubMedSearch in Google Scholar
  • 73 Sporea I, Badea R, Martie A. et al. Contrast Enhanced Ultrasound for the evaluation of focal liver lesions in daily practice. A multicentre study. Med Ultrason 2012; 14: 95-100
    PubMedSearch in Google Scholar
  • 74 Sporea I, Badea R, Popescu A. et al. Contrast-enhanced ultrasound (CEUS) for the evaluation of focal liver lesions – a prospective multicenter study of its usefulness in clinical practice. Ultraschall in Med 2014; 35: 259-266
    Thieme ConnectPubMedSearch in Google Scholar
  • 75 Xie L, Guang Y, Ding H. et al. Diagnostic value of contrast-enhanced ultrasound, computed tomography and magnetic resonance imaging for focal liver lesions: a meta-analysis. Ultrasound Med Biol 2011; 37: 854-861
    CrossrefPubMedSearch in Google Scholar
  • 76 Dietrich CF, Mertens JC, Braden B. et al. Contrast-enhanced ultrasound of histologically proven liver hemangiomas. Hepatology 2007; 45: 1139-1145
    CrossrefPubMedSearch in Google Scholar
  • 77 Dietrich CF, Schuessler G, Trojan J. et al. Differentiation of focal nodular hyperplasia and hepatocellular adenoma by contrast-enhanced ultrasound. Br J Radiol 2005; 78: 704-707
    CrossrefPubMedSearch in Google Scholar
  • 78 Trojan J, Hammerstingl R, Engels K. et al. Contrast-enhanced ultrasound in the diagnosis of malignant mesenchymal liver tumors. J Clin Ultrasound 2010; 38: 227-231
    PubMedSearch in Google Scholar
  • 79 Bartolotta TV, Sandonato L, Taibbi A. et al. Focal liver lesions: clinical usefulness of contrast-enhanced ultrasound in the selection of surgical patients. Chir Ital 2009; 61: 295-307
    PubMedSearch in Google Scholar
  • 80 Westwood M, Joore M, Grutters J. et al. Contrast-enhanced ultrasound using SonoVue(R) (sulphur hexafluoride microbubbles) compared with contrast-enhanced computed tomography and contrast-enhanced magnetic resonance imaging for the characterisation of focal liver lesions and detection of liver metastases: a systematic review and cost-effectiveness analysis. Health Technol Assess 2013; 17: 1-243
    CrossrefPubMedSearch in Google Scholar
  • 81 Kaltenbach TE, Engler P, Kratzer W. et al. Prevalence of benign focal liver lesions: ultrasound investigation of 45319 hospital patients. Abdom Radiol (NY) 2016; 41: 25-32
    CrossrefPubMedSearch in Google Scholar
  • 82 Dietrich CF, Sharma M, Gibson RN. et al. Fortuitously discovered liver lesions. World J Gastroenterol 2013; 19: 3173-3188
    CrossrefPubMedSearch in Google Scholar
  • 83 Vidili G, De Sio I, D’Onofrio M. et al. SIUMB guidelines and recommendations for the correct use of ultrasound in the management of patients with focal liver disease. J Ultrasound 2019; 22: 41-51
    CrossrefPubMedSearch in Google Scholar
  • 84 Cui XW, Ignee A, Jedrzejczyk M. et al. Dynamic Vascular Pattern (DVP), a quantification tool for contrast enhanced ultrasound. Z Gastroenterol 2013; 51: 427-431
    Thieme ConnectPubMedSearch in Google Scholar
  • 85 Sienz M, Ignee A, Dietrich CF. Reference values in abdominal ultrasound – biliopancreatic system and spleen. Z Gastroenterol 2011; 49: 845-870
    Thieme ConnectPubMedSearch in Google Scholar
  • 86 Chiorean L, Cui XW, Tannapfel A. et al. Benign liver tumors in pediatric patients – Review with emphasis on imaging features. World J Gastroenterol 2015; 21: 8541-8561
    CrossrefPubMedSearch in Google Scholar
  • 87 Foschi FG, Dall’Aglio AC, Marano G. et al. Role of contrast-enhanced ultrasonography in primary hepatic lymphoma. J Ultrasound Med 2010; 29: 1353-1356
    CrossrefPubMedSearch in Google Scholar
  • 88 Inoue T, Hyodo T, Korenaga K. et al. Kupffer phase image of Sonazoid-enhanced US is useful in predicting a hypervascularization of non-hypervascular hypointense hepatic lesions detected on Gd-EOB-DTPA-enhanced MRI: a multicenter retrospective study. J Gastroenterol 2016; 51: 144-152
    CrossrefPubMedSearch in Google Scholar
  • 89 Sienz M, Ignee A, Dietrich CF. Sonography today: reference values in abdominal ultrasound: aorta, inferior vena cava, kidneys. Z Gastroenterol 2012; 50: 293-315
    Thieme ConnectPubMedSearch in Google Scholar
  • 90 Dietrich CF, Tannapfel A, Jang HJ. et al. Ultrasound Imaging of Hepatocellular Adenoma Using the New Histology Classification. Ultrasound Med Biol 2019; 45: 1-10
    CrossrefPubMedSearch in Google Scholar
  • 91 Lamuraglia M, Escudier B, Chami L. et al. To predict progression-free survival and overall survival in metastatic renal cancer treated with sorafenib: pilot study using dynamic contrast-enhanced Doppler ultrasound. Eur J Cancer 2006; 42: 2472-2479
    CrossrefPubMedSearch in Google Scholar
  • 92 Hirche TO, Ignee A, Hirche H. et al. Evaluation of hepatic steatosis by ultrasound in patients with chronic hepatitis C virus infection. Liver Int 2007; 27: 748-757
    CrossrefPubMedSearch in Google Scholar
  • 93 Little JM, Richardson A, Tait N. Hepatic dystychoma: a five year experience. HPB Surg 1991; 4: 291-297
    CrossrefPubMedSearch in Google Scholar
  • 94 Sugimoto K, Moriyasu F, Saito K. et al. Kupffer-phase findings of hepatic hemangiomas in contrast-enhanced ultrasound with sonazoid. Ultrasound Med Biol 2014; 40: 1089-1095
    CrossrefPubMedSearch in Google Scholar
  • 95 Chiorean L, Caraiani C, Radzina M. et al. Vascular phases in imaging and their role in focal liver lesions assessment. Clin Hemorheol Microcirc 2015; 62: 299-326
    CrossrefPubMedSearch in Google Scholar
  • 96 Klinger C, Stuckmann G, Dietrich CF. et al. Contrast-enhanced imaging in hepatic epithelioid hemangioendothelioma: retrospective study of 10 patients. Z Gastroenterol 2019; 57: 753-766
    Thieme ConnectPubMedSearch in Google Scholar
  • 97 Piscaglia F, Gianstefani A, Ravaioli M. et al. Criteria for diagnosing benign portal vein thrombosis in the assessment of patients with cirrhosis and hepatocellular carcinoma for liver transplantation. Liver Transpl 2010; 16: 658-667
    CrossrefPubMedSearch in Google Scholar
  • 98 Dietrich CF, Tana C, Caraiani C. et al. Contrast enhanced ultrasound (CEUS) imaging of solid benign focal liver lesions. Expert Rev Gastroenterol Hepatol 2018; 12: 479-489
    CrossrefPubMedSearch in Google Scholar
  • 99 Piscaglia F, Venturi A, Mancini M. et al. Diagnostic features of real-time contrast-enhanced ultrasound in focal nodular hyperplasia of the liver. Ultraschall in Med 2010; 31: 276-282
    Thieme ConnectPubMedSearch in Google Scholar
  • 100 Pei XQ, Liu LZ, Xiong YH. et al. Quantitative analysis of contrast-enhanced ultrasonography: differentiating focal nodular hyperplasia from hepatocellular carcinoma. Br J Radiol 2013; 86: 20120536
    CrossrefPubMedSearch in Google Scholar
  • 101 Jones EC, Chezmar JL, Nelson RC. et al. The frequency and significance of small (less than or equal to 15 mm) hepatic lesions detected by CT. Am J Roentgenol 1992; 158: 535-539
    CrossrefPubMedSearch in Google Scholar
  • 102 Lee J, Jeong WK, Lim HK. et al. Focal Nodular Hyperplasia of the Liver: Contrast-Enhanced Ultrasonographic Features With Sonazoid. J Ultrasound Med 2018; 37: 1473-1480
    CrossrefPubMedSearch in Google Scholar
  • 103 Janica J, Ustymowicz A, Lukasiewicz A. et al. Comparison of contrast-enhanced ultrasonography with grey-scale ultrasonography and contrast-enhanced computed tomography in diagnosing focal fatty liver infiltrations and focal fatty sparing. Adv Med Sci 2013; 58: 408-418
    CrossrefPubMedSearch in Google Scholar
  • 104 Dietrich CF, Jenssen C. Focal liver lesion, incidental finding. Dtsch Med Wochenschr 2012; 137: 2099-2116
    Thieme ConnectPubMedSearch in Google Scholar
  • 105 Catalano O, Sandomenico F, Nunziata A. et al. Transient hepatic echogenicity difference on contrast-enhanced ultrasonography: sonographic sign and pitfall. J Ultrasound Med 2007; 26: 337-345
    CrossrefPubMedSearch in Google Scholar
  • 106 Catalano O, Sandomenico F, Raso MM. et al. Low mechanical index contrast-enhanced sonographic findings of pyogenic hepatic abscesses. Am J Roentgenol 2004; 182: 447-450
    CrossrefPubMedSearch in Google Scholar
  • 107 Liu GJ, Lu MD, Xie XY. et al. Real-time contrast-enhanced ultrasound imaging of infected focal liver lesions. J Ultrasound Med 2008; 27: 657-666
    CrossrefPubMedSearch in Google Scholar
  • 108 Biecker E, Fischer HP, Strunk H. et al. Benign hepatic tumours. Z Gastroenterol 2003; 41: 191-200
    Thieme ConnectPubMedSearch in Google Scholar
  • 109 Anderson SW, Kruskal JB, Kane RA. Benign hepatic tumors and iatrogenic pseudotumors. Radiographics 2009; 29: 211-229
    CrossrefPubMedSearch in Google Scholar
  • 110 Cao BS, Li XL, Li N. et al. The nodular form of hepatic tuberculosis: contrast-enhanced ultrasonographic findings with pathologic correlation. J Ultrasound Med 2010; 29: 881-888
    CrossrefPubMedSearch in Google Scholar
  • 111 Dietrich CF, Atkinson NSS, Lee WJ. et al. Never seen before? Opisthorchiasis and Clonorchiasis. Z Gastroenterol 2018; 56: 1513-1520
    Thieme ConnectPubMedSearch in Google Scholar
  • 112 Dietrich CF, Kabaalioglu A, Brunetti E. et al. Fasciolosis. Z Gastroenterol 2015; 53: 285-290
    Thieme ConnectPubMedSearch in Google Scholar
  • 113 Wang Z, Xu HX, Xie XY. et al. Imaging features of hepatic angiomyolipomas on real-time contrast-enhanced ultrasound. Br J Radiol 2010; 83: 411-418
    CrossrefPubMedSearch in Google Scholar
  • 114 Corvino A, Catalano O, Setola SV. et al. Contrast-enhanced ultrasound in the characterization of complex cystic focal liver lesions. Ultrasound Med Biol 2015; 41: 1301-1310
    CrossrefPubMedSearch in Google Scholar
  • 115 Ignee A, Piscaglia F, Ott M. et al. A benign tumour of the liver mimicking malignant liver disease – cholangiocellular adenoma. Scand J Gastroenterol 2009; 44: 633-636
    CrossrefPubMedSearch in Google Scholar
  • 116 Dong Y, Wang WP, Cantisani V. et al. Contrast-enhanced ultrasound of histologically proven hepatic epithelioid hemangioendothelioma. World J Gastroenterol 2016; 22: 4741-4749
    CrossrefPubMedSearch in Google Scholar
  • 117 Cui XW, Ignee A, Woenckhaus M. et al. Hemangioendothelioma, an imaging challenge. Endheu 2014; 27: 34-36
    PubMedSearch in Google Scholar
  • 118 Lu SN, Wang LY, Chang WY. et al. Abdominal sonographic screening in a single community. Gaoxiong Yi Xue Ke Xue Za Zhi 1990; 6: 643-646
    PubMedSearch in Google Scholar
  • 119 Forner A, Llovet JM, Bruix J. Hepatocellular carcinoma. Lancet 2012; 379: 1245-1255
    CrossrefPubMedSearch in Google Scholar
  • 120 Zheng SG, Xu HX, Liu LN. Management of hepatocellular carcinoma: The role of contrast-enhanced ultrasound. World J Radiol 2014; 6: 7-14
    CrossrefPubMedSearch in Google Scholar
  • 121 Hayashi H, Nishigaki Y, Tomita E. et al. Usefulness of early vascular phase images from contrast-enhanced ultrasonography using Sonazoid for the diagnosis of hypovascular hepatocellular carcinoma. Hepatol Res 2016; 46: 497-504
    CrossrefPubMedSearch in Google Scholar
  • 122 Goto E, Masuzaki R, Tateishi R. et al. Value of post-vascular phase (Kupffer imaging) by contrast-enhanced ultrasonography using Sonazoid in the detection of hepatocellular carcinoma. J Gastroenterol 2012; 47: 477-485
    CrossrefPubMedSearch in Google Scholar
  • 123 Mandry D, Bressenot A, Galloy MA. et al. Contrast-enhanced ultrasound in fibro-lamellar hepatocellular carcinoma: a case report. Ultraschall in Med 2007; 28: 547-552
    Thieme ConnectPubMedSearch in Google Scholar
  • 124 Arita J, Hasegawa K, Takahashi M. et al. Correlation between contrast-enhanced intraoperative ultrasound using Sonazoid and histologic grade of resected hepatocellular carcinoma. Am J Roentgenol 2011; 196: 1314-1321
    CrossrefPubMedSearch in Google Scholar
  • 125 Galassi M, Iavarone M, Rossi S. et al. Patterns of appearance and risk of misdiagnosis of intrahepatic cholangiocarcinoma in cirrhosis at contrast enhanced ultrasound. Liver Int 2013; 33: 771-779
    CrossrefPubMedSearch in Google Scholar
  • 126 Dong Y, Teufel A, Trojan J. et al. Contrast enhanced ultrasound in mixed hepatocellular cholangiocarcinoma: Case series and review of the literature. Dig Liver Dis 2018; 50: 401-407
    CrossrefPubMedSearch in Google Scholar
  • 127 Chen LD, Xu HX, Xie XY. et al. Enhancement patterns of intrahepatic cholangiocarcinoma: comparison between contrast-enhanced ultrasound and contrast-enhanced CT. Br J Radiol 2008; 81: 881-889
    CrossrefPubMedSearch in Google Scholar
  • 128 Schellhaas B, Pfeifer L, Kielisch C. et al. Interobserver Agreement for Contrast-Enhanced Ultrasound (CEUS)-Based Standardized Algorithms for the Diagnosis of Hepatocellular Carcinoma in High-Risk Patients. Ultraschall in Med 2018; 39: 667-674
    Thieme ConnectPubMedSearch in Google Scholar
  • 129 Schellhaas B, Hammon M, Strobel D. et al. Interobserver and intermodality agreement of standardized algorithms for non-invasive diagnosis of hepatocellular carcinoma in high-risk patients: CEUS-LI-RADS versus MRI-LI-RADS. Eur Radiol 2018; 28: 4254-4264
    CrossrefPubMedSearch in Google Scholar
  • 130 Barreiros AP, Piscaglia F, Dietrich CF. Contrast enhanced ultrasound for the diagnosis of hepatocellular carcinoma (HCC): Comments on AASLD guidelines. J Hepatol 2012; 57: 930-932
    CrossrefPubMedSearch in Google Scholar
  • 131 Dietrich CF, Cui XW, Boozari B. et al. Contrast-enhanced ultrasound (CEUS) in the diagnostic algorithm of hepatocellular and cholangiocellular carcinoma, comments on the AASLD guidelines. Ultraschall in Med 2012; 33: S57-S66
    Thieme ConnectPubMedSearch in Google Scholar
  • 132 Leoni S, Piscaglia F, Golfieri R. et al. The impact of vascular and nonvascular findings on the noninvasive diagnosis of small hepatocellular carcinoma based on the EASL and AASLD criteria. Am J Gastroenterol 2010; 105: 599-609
    CrossrefPubMedSearch in Google Scholar
  • 133 Piscaglia F, Wilson SR, Lyshchik A. et al. American College of Radiology Contrast Enhanced Ultrasound Liver Imaging Reporting and Data System (CEUS LI-RADS) for the diagnosis of Hepatocellular Carcinoma: a pictorial essay. Ultraschall in Med 2017; 38: 320-324
    Thieme ConnectPubMedSearch in Google Scholar
  • 134 Kono Y, Lyshchik A, Cosgrove D. et al. Contrast Enhanced Ultrasound (CEUS) Liver Imaging Reporting and Data System (LI-RADS(R)): the official version by the American College of Radiology (ACR). Ultraschall in Med 2017; 38: 85-86
    Thieme ConnectPubMedSearch in Google Scholar
  • 135 Kim TK, Noh SY, Wilson SR. et al. Contrast-enhanced ultrasound (CEUS) liver imaging reporting and data system (LI-RADS) 2017 – a review of important differences compared to the CT/MRI system. Clin Mol Hepatol 2017; 23: 280-289
    CrossrefPubMedSearch in Google Scholar
  • 136 Zech CJ. Incidental livers lesions – a modern approach. MMW Fortschr Med 2011; 153: 41-44 ; quiz 45
    PubMedSearch in Google Scholar
  • 137 Frydrychowicz A, Lubner MG, Brown JJ. et al. Hepatobiliary MR imaging with gadolinium-based contrast agents. J Magn Reson Imaging 2012; 35: 492-511
    CrossrefPubMedSearch in Google Scholar
  • 138 Xu HX, Chen LD, Liu LN. et al. Contrast-enhanced ultrasound of intrahepatic cholangiocarcinoma: correlation with pathological examination. Br J Radiol 2012; 85: 1029-1037
    CrossrefPubMedSearch in Google Scholar
  • 139 Dietrich CF, Serra C, Jedrejczyk M. Chapter 2, Ultrasound of liver. In: Dietrich CF. ed EFSUMB Europen Course Book. London: Latimer Trend & Company Ltd; 2012: 27-55
    Search in Google Scholar
  • 140 Ying L, Lin X, Xie ZL. et al. Clinical utility of acoustic radiation force impulse imaging for identification of malignant liver lesions: a meta-analysis. Eur Radiol 2012; 22: 2798-2805
    CrossrefPubMedSearch in Google Scholar
  • 141 Hatanaka K, Kudo M, Minami Y. et al. Differential diagnosis of hepatic tumors: value of contrast-enhanced harmonic sonography using the newly developed contrast agent, Sonazoid. Intervirology 2008; 51 (Suppl. 01) 61-69
    CrossrefPubMedSearch in Google Scholar
  • 142 Trenker C, Kunsch S, Michl P. et al. Contrast-enhanced ultrasound (CEUS) in hepatic lymphoma: retrospective evaluation in 38 cases. Ultraschall in Med 2014; 35: 142-148
    Thieme ConnectPubMedSearch in Google Scholar
  • 143 Heller E, Gorg C. Focal liver lesions in patients with malignant haematological disease: value of B-mode ultrasound in comparison to contrast-enhanced ultrasound – a retrospective study with N = 61 patients. Z Gastroenterol 2013; 51: 558-567
    Thieme ConnectPubMedSearch in Google Scholar
  • 144 Zhang YL, Yuan L, Shen H. et al. Haemorrhagic hepatic cysts mimicking biliary cystadenoma. World J Gastroenterol 2009; 15: 4601-4603
    CrossrefPubMedSearch in Google Scholar
  • 145 Corvino A, Catalano O, Corvino F. et al. Diagnostic Performance and Confidence of Contrast-Enhanced Ultrasound in the Differential Diagnosis of Cystic and Cysticlike Liver Lesions. Am J Roentgenol 2017; 209: W119-W127
    CrossrefPubMedSearch in Google Scholar
  • 146 Vachha B, Sun MR, Siewert B. et al. Cystic lesions of the liver. Am J Roentgenol 2011; 196: W355-W366
    CrossrefPubMedSearch in Google Scholar
  • 147 Cha EY, Kim KW, Choi YJ. et al. Multicystic cavernous haemangioma of the liver: Ultrasonography, CT, MR appearances and pathologic correlation. Br J Radiol 2008; 81: e37-e39
    CrossrefPubMedSearch in Google Scholar
  • 148 Barreiros AP, Chiorean L, Braden B. et al. Ultrasound in rare diffuse liver disease. Z Gastroenterol 2014; 52: 1247-1256
    Thieme ConnectPubMedSearch in Google Scholar
  • 149 Lin MX, Xu HX, Lu MD. et al. Diagnostic performance of contrast-enhanced ultrasound for complex cystic focal liver lesions: Blinded liver study. Eur Radiol 2009; 19: 358-369
    CrossrefPubMedSearch in Google Scholar
  • 150 Mork H, Ignee A, Schuessler G. et al. Analysis of neuroendocrine tumour metastases in the liver using contrast enhanced ultrasonography. Scand J Gastroenterol 2007; 42: 652-662
    CrossrefPubMedSearch in Google Scholar
  • 151 Piscaglia F, Lencioni R, Sagrini E. et al. Characterization of focal liver lesions with contrast-enhanced ultrasound. Ultrasound Med Biol 2010; 36: 531-550
    CrossrefPubMedSearch in Google Scholar
  • 152 Wang JY, Feng SY, Xu JW. et al. Usefulness of the Contrast-Enhanced Ultrasound Liver Imaging Reporting and Data System in Diagnosing Focal Liver Lesions by Inexperienced Radiologists. J Ultrasound Med 2020; Feb 20
    CrossrefPubMedSearch in Google Scholar
  • 153 Rodgers SK, Fetzer DT, Gabriel H. et al. Role of US LI-RADS in the LI-RADS Algorithm. Radiographics 2019; 39: 690-708
    CrossrefPubMedSearch in Google Scholar
  • 154 Dietrich CF, Potthoff A, Helmberger T. et al. Contrast-enhanced ultrasound: Liver Imaging Reporting and Data System (CEUS LI-RADS). Z Gastroenterol 2018; 56: 499-506
    PubMedSearch in Google Scholar
  • 155 Kono Y, Sirlin CB, Fetzer DT. et al. Time to Clarify Common Misconceptions about the Liver Imaging Reporting and Data System for Contrast-enhanced US. Radiology 2020; 295: 245-247
    CrossrefPubMedSearch in Google Scholar
  • 156 Lyshchik A, Kono Y, Dietrich CF. et al. Contrast-enhanced ultrasound of the liver: technical and lexicon recommendations from the ACR CEUS LI-RADS working group. Abdom Radiol (NY) 2018; 43: 861-879
    CrossrefPubMedSearch in Google Scholar
  • 157 Terzi E, Iavarone M, Pompili M. et al. Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1006 nodules. J Hepatol 2018; 68: 485-492
    CrossrefPubMedSearch in Google Scholar
  • 158 Sangiovanni A, Manini MA, Iavarone M. et al. The diagnostic and economic impact of contrast imaging techniques in the diagnosis of small hepatocellular carcinoma in cirrhosis. Gut 2010; 59: 638-644
    CrossrefPubMedSearch in Google Scholar
  • 159 Boozari B, Soudah B, Rifai K. et al. Grading of hypervascular hepatocellular carcinoma using late phase of contrast enhanced sonography – a prospective study. Dig Liver Dis 2011; 43: 484-490
    CrossrefPubMedSearch in Google Scholar
  • 160 Fan ZH, Chen MH, Dai Y. et al. Evaluation of primary malignancies of the liver using contrast-enhanced sonography: correlation with pathology. Am J Roentgenol 2006; 186: 1512-1519
    CrossrefPubMedSearch in Google Scholar
  • 161 Iavarone M, Sangiovanni A, Forzenigo LV. et al. Diagnosis of hepatocellular carcinoma in cirrhosis by dynamic contrast imaging: the importance of tumor cell differentiation. Hepatology 2010; 52: 1723-1730
    CrossrefPubMedSearch in Google Scholar
  • 162 Jang HJ, Kim TK, Burns PN. et al. Enhancement patterns of hepatocellular carcinoma at contrast-enhanced US: comparison with histologic differentiation. Radiology 2007; 244: 898-906
    CrossrefPubMedSearch in Google Scholar
  • 163 Wildner D, Bernatik T, Greis C. et al. CEUS in hepatocellular carcinoma and intrahepatic cholangiocellular carcinoma in 320 patients – early or late washout matters: a subanalysis of the DEGUM multicenter trial. Ultraschall in Med 2015; 36: 132-139
    Thieme ConnectPubMedSearch in Google Scholar
  • 164 Chen MH, Dai Y, Yan K. et al. The role of contrast-enhanced ultrasound on the diagnosis of small hepatocellular carcinoma (</= 3 cm) in patients with cirrhosis. Hepatol Res 2006; 35: 281-288
    CrossrefPubMedSearch in Google Scholar
  • 165 Dietrich CF, Kono Y, Cosgrove D. et al Contrast-Enhanced Ultrasound: Liver Imaging Reporting and Data System (CEUS LI-RADS). In: Solutions in contrast imaging: Solutions in CONTRAST IMAGING 2016
    PubMedSearch in Google Scholar
  • 166 Schellhaas B, Gortz RS, Pfeifer L. et al. Diagnostic accuracy of contrast-enhanced ultrasound for the differential diagnosis of hepatocellular carcinoma: ESCULAP versus CEUS-LI-RADS. Eur J Gastroenterol Hepatol 2017; 29: 1036-1044
    CrossrefPubMedSearch in Google Scholar
  • 167 Tarantino L, Francica G, Sordelli I. et al. Diagnosis of benign and malignant portal vein thrombosis in cirrhotic patients with hepatocellular carcinoma: color Doppler US, contrast-enhanced US, and fine-needle biopsy. Abdom Imaging 2006; 31: 537-544
    CrossrefPubMedSearch in Google Scholar
  • 168 Chammas MC, Oliveira AC, MJ DA. et al. Characterization of Malignant Portal Vein Thrombosis with Contrast-Enhanced Ultrasonography. Ultrasound Med Biol 2019; 45: 50-55
    CrossrefPubMedSearch in Google Scholar
  • 169 Raza SA, Jang HJ, Kim TK. Differentiating malignant from benign thrombosis in hepatocellular carcinoma: Contrast-enhanced ultrasound. Abdominal Imaging 2014; 39: 153-161
    CrossrefPubMedSearch in Google Scholar
  • 170 Dănilă M, Sporea I, Popescu A. et al. The value of contrast enhanced ultrasound in the evaluation of the nature of portal vein thrombosis. Med Ultrason 2011; 13: 102-107
    PubMedSearch in Google Scholar
  • 171 Song ZZ, Huang M, Jiang TA. et al. Diagnosis of portal vein thrombosis discontinued with liver tumors in patients with liver cirrhosis and tumors by contrast-enhanced US: a pilot study. Eur J Radiol 2010; 75: 185-188
    CrossrefPubMedSearch in Google Scholar
  • 172 Ueno N, Kawamura H, Takahashi H. et al. Characterization of portal vein thrombus with the use of contrast-enhanced sonography. Journal of Ultrasound in Medicine 2006; 25: 1147-1152
    CrossrefPubMedSearch in Google Scholar
  • 173 Rossi S, Rosa L, Ravetta V. et al. Contrast-enhanced versus conventional and color Doppler sonography for the detection of thrombosis of the portal and hepatic venous systems. Am J Roentgenol 2006; 186: 763-773
    CrossrefPubMedSearch in Google Scholar
  • 174 Sorrentino P, D’Angelo S, Tarantino L. et al. Contrast-enhanced sonography versus biopsy for the differential diagnosis of thrombosis in hepatocellular carcinoma patients. World J Gastroenterol 2009; 15: 2245-2251
    CrossrefPubMedSearch in Google Scholar
  • 175 Torzilli G, Del Fabbro D, Olivari N. et al. Contrast-enhanced ultrasonography during liver surgery. Br J Surg 2004; 91: 1165-1167
    CrossrefPubMedSearch in Google Scholar
  • 176 Torzilli G, Palmisano A, Del Fabbro D. et al Contrast-enhanced intraoperative ultrasonography during surgery for hepatocellular carcinoma in liver cirrhosis: is it useful or useless? A prospective cohort study of our experience. Ann Surg Oncol 2007; 14: 1347-1355
    CrossrefPubMedSearch in Google Scholar
  • 177 Torzilli G, Botea F, Donadon M. et al. Criteria for the selective use of contrast-enhanced intra-operative ultrasound during surgery for colorectal liver metastases. HPB (Oxford) 2014; 16: 994-1001
    CrossrefPubMedSearch in Google Scholar
  • 178 Fioole B, de Haas RJ, Wicherts DA. et al. Additional value of contrast enhanced intraoperative ultrasound for colorectal liver metastases. Eur J Radiol 2008; 67: 169-176
    CrossrefPubMedSearch in Google Scholar
  • 179 Nakano H, Ishida Y, Hatakeyama T. et al. Contrast-enhanced intraoperative ultrasonography equipped with late Kupffer-phase image obtained by sonazoid in patients with colorectal liver metastases. World J Gastroenterol 2008; 14: 3207-3211
    CrossrefPubMedSearch in Google Scholar
  • 180 Arita J, Takahashi M, Hata S. et al. Usefulness of contrast-enhanced intraoperative ultrasound using Sonazoid in patients with hepatocellular carcinoma. Ann Surg 2011; 254: 992-999
    CrossrefPubMedSearch in Google Scholar
  • 181 Huf S, Platz Batista da Silva N, Wiesinger I. et al. Analysis of Liver Tumors Using Preoperative and Intraoperative Contrast-Enhanced Ultrasound (CEUS/IOCEUS) by Radiologists in Comparison to Magnetic Resonance Imaging and Histopathology. Rofo 2017; 189: 431-440
    Thieme ConnectPubMedSearch in Google Scholar
  • 182 Leen E, Ceccotti P, Moug SJ. et al. Potential value of contrast-enhanced intraoperative ultrasonography during partial hepatectomy for metastases: an essential investigation before resection?. Ann Surg 2006; 243: 236-240
    CrossrefPubMedSearch in Google Scholar
  • 183 Jones RP, Vauthey JN, Adam R. et al. Effect of specialist decision-making on treatment strategies for colorectal liver metastases. Br J Surg 2012; 99: 1263-1269
    CrossrefPubMedSearch in Google Scholar
  • 184 Lorentzen T, Nolsoe CP, Ewertsen C. et al. EFSUMB Guidelines on Interventional Ultrasound (INVUS), Part I. General Aspects (Short Version). Ultraschall in Med 2015; 36: 464-472
    Thieme ConnectPubMedSearch in Google Scholar
  • 185 Sidhu PS, Brabrand K, Cantisani V. et al. EFSUMB Guidelines on Interventional Ultrasound (INVUS), Part II. Diagnostic Ultrasound-Guided Interventional Procedures (Short Version). Ultraschall in Med 2015; 36: 566-580
    Thieme ConnectPubMedSearch in Google Scholar
  • 186 Francica G, Meloni MF, de Sio I. et al. Biopsy of Liver Target Lesions under Contrast-Enhanced Ultrasound Guidance – A Multi-Center Study. Ultraschall in Med 2018; 39: 448-453
    Thieme ConnectPubMedSearch in Google Scholar
  • 187 Wu W, Chen MH, Yin SS. et al. The role of contrast-enhanced sonography of focal liver lesions before percutaneous biopsy. Am J Roentgenol 2006; 187: 752-761
    CrossrefPubMedSearch in Google Scholar
  • 188 Cao X, Liu Z, Zhou X. et al. Usefulness of real-time contrast-enhanced ultrasound guided coaxial needle biopsy for focal liver lesions. Abdom Radiol (NY) 2019; 44: 310-317
    CrossrefPubMedSearch in Google Scholar
  • 189 Sparchez Z, Radu P, Kacso G. et al. Prospective comparison between real time contrast enhanced and conventional ultrasound guidance in percutaneous biopsies of liver tumors. Med Ultrason 2015; 17: 456-463
    PubMedSearch in Google Scholar
  • 190 Nolsoe CP, Nolsoe AB, Klubien J. et al. Use of Ultrasound Contrast Agents in Relation to Percutaneous Interventional Procedures: A Systematic Review and Pictorial Essay. J Ultrasound Med 2018; 37: 1305-1324
    CrossrefPubMedSearch in Google Scholar
  • 191 Bang N, Bachmann Nielsen M, Vejborg I. et al. Clinical report: contrast enhancement of tumor perfusion as a guidance for biopsy. Eur J Ultrasound 2000; 12: 159-161
    CrossrefPubMedSearch in Google Scholar
  • 192 Eso Y, Takai A, Takeda H. et al. Sonazoid-enhanced ultrasonography guidance improves the quality of pathological diagnosis in the biopsy of focal hepatic lesions. Eur J Gastroenterol Hepatol 2016; 28: 1462-1467
    CrossrefPubMedSearch in Google Scholar
  • 193 Skjoldbye B, Pedersen MH, Struckmann J. et al. Improved detection and biopsy of solid liver lesions using pulse-inversion ultrasound scanning and contrast agent infusion. Ultrasound Med Biol 2002; 28: 439-444
    CrossrefPubMedSearch in Google Scholar
  • 194 Schlottmann K, Klebl F, Zorger N. et al. Contrast-enhanced ultrasound allows for interventions of hepatic lesions which are invisible on convential B-mode. Z Gastroenterol 2004; 42: 303-310
    Thieme ConnectPubMedSearch in Google Scholar
  • 195 Yoon SH, Lee KH, Kim SY. et al. Real-time contrast-enhanced ultrasound-guided biopsy of focal hepatic lesions not localised on B-mode ultrasound. Eur Radiol 2010; 20: 2047-2056
    CrossrefPubMedSearch in Google Scholar
  • 196 Park HS, Kim YJ, Yu MH. et al. Real-time contrast-enhanced sonographically guided biopsy or radiofrequency ablation of focal liver lesions using perflurobutane microbubbles (sonazoid): value of Kupffer-phase imaging. J Ultrasound Med 2015; 34: 411-421
    CrossrefPubMedSearch in Google Scholar
  • 197 Kang TW, Lee MW, Song KD. et al. Added Value of Contrast-Enhanced Ultrasound on Biopsies of Focal Hepatic Lesions Invisible on Fusion Imaging Guidance. Korean J Radiol 2017; 18: 152-161
    CrossrefPubMedSearch in Google Scholar
  • 198 Kang HJ, Kim JH, Lee SM. et al. Additional value of contrast-enhanced ultrasonography for fusion-guided, percutaneous biopsies of focal liver lesions: prospective feasibility study. Abdom Radiol (NY) 2018; 43: 3279-3287
    CrossrefPubMedSearch in Google Scholar
  • 199 Lorentzen T, Nolsoe CP, Ewertsen C. et al. EFSUMB Guidelines on Interventional Ultrasound (INVUS), Part I. General Aspects (long Version). Ultraschall in Med 2015; 36: E1-E14
    Thieme ConnectPubMedSearch in Google Scholar
  • 200 Yusuf GT, Fang C, Huang DY. et al. Endocavitary contrast enhanced ultrasound (CEUS): a novel problem solving technique. Insights Imaging 2018; 9: 303-311
    CrossrefPubMedSearch in Google Scholar
  • 201 Cui XW, Ignee A, Baum U. et al. Feasibility and usefulness of using swallow contrast-enhanced ultrasound to diagnose Zenker’s diverticulum: preliminary results. Ultrasound Med Biol 2015; 41: 975-981
    CrossrefPubMedSearch in Google Scholar
  • 202 Cui XW, Ignee A, Maros T. et al. Feasibility and Usefulness of Intra-Cavitary Contrast-Enhanced Ultrasound in Percutaneous Nephrostomy. Ultrasound Med Biol 2016; 42: 2180-2188
    CrossrefPubMedSearch in Google Scholar
  • 203 Heinzmann A, Muller T, Leitlein J. et al. Endocavitary contrast enhanced ultrasound (CEUS)--work in progress. Ultraschall in Med 2012; 33: 76-84
    Thieme ConnectPubMedSearch in Google Scholar
  • 204 Ignee A, Schuessler G, Cui XW. et al Intracavitary contrast medium ultrasound – different applications, a review of the literature ad future prospects. Ultraschall in Med 2013; 34: 504-525 ; quiz 526–508
    Thieme ConnectPubMedSearch in Google Scholar
  • 205 Ignee A, Jenssen C, Cui XW. et al. Intracavitary contrast-enhanced ultrasound in abscess drainage--feasibility and clinical value. Scand J Gastroenterol 2016; 51: 41-47
    CrossrefPubMedSearch in Google Scholar
  • 206 Ignee A, Cui X, Schuessler G. et al. Percutaneous transhepatic cholangiography and drainage using extravascular contrast enhanced ultrasound. Z Gastroenterol 2015; 53: 385-390
    Thieme ConnectPubMedSearch in Google Scholar
  • 207 Ignee A, Baum U, Schuessler G. et al. Contrast-enhanced ultrasound-guided percutaneous cholangiography and cholangiodrainage (CEUS-PTCD). Endoscopy 2009; 41: 725-726
    Thieme ConnectPubMedSearch in Google Scholar
  • 208 Urade T, Fukumoto T, Tanaka M. et al. Contrast-enhanced intraoperative ultrasonic cholangiography for real-time biliary navigation in hepatobiliary surgery. J Am Coll Surg 2014; 218: e43-e50
    CrossrefPubMedSearch in Google Scholar
  • 209 Chopra SS, Eisele R, Stelter L. et al. Contrast enhanced ultrasound cholangiography via T-tube following liver transplantation. Ann Transplant 2012; 17: 108-112
    CrossrefPubMedSearch in Google Scholar
  • 210 Daneshi M, Rajayogeswaran B, Peddu P. et al. Demonstration of an occult biliary-arterial fistula using percutaneous contrast-enhanced ultrasound cholangiography in a transplanted liver. J Clin Ultrasound 2014; 42: 108-111
    CrossrefPubMedSearch in Google Scholar
  • 211 Mao R, Xu EJ, Li K. et al. Usefulness of contrast-enhanced ultrasound in the diagnosis of biliary leakage following T-tube removal. J Clin Ultrasound 2010; 38: 38-40
    PubMedSearch in Google Scholar
  • 212 Xu EJ, Mao R, Zheng RQ. et al. Three-dimensional contrast-enhanced ultrasonic cholangiography: a new technique for delineation of the biliary tract in a liver donor. Liver Transpl 2009; 15: 1154-1156
    CrossrefPubMedSearch in Google Scholar
  • 213 Zheng RQ, Chen GH, Xu EJ. et al. Evaluating biliary anatomy and variations in living liver donors by a new technique: three-dimensional contrast-enhanced ultrasonic cholangiography. Ultrasound Med Biol 2010; 36: 1282-1287
    CrossrefPubMedSearch in Google Scholar
  • 214 Velosa M, Lopes S, Castro R. et al. Cholecystoduodenal fistula diagnosed with contrast-enhanced endoscopic ultrasound. Endoscopy 2013; 45 (Suppl. 02) E18-E19
    Thieme ConnectPubMedSearch in Google Scholar
  • 215 Zuber-Jerger I, Endlicher E, Scholmerich J. et al. Endoscopic retrograde cholangiography with contrast ultrasonography. Endoscopy 2008; 40 (Suppl. 02) E202
    Thieme ConnectPubMedSearch in Google Scholar
  • 216 Luyao Z, Xiaoyan X, Huixiong X. et al. Percutaneous ultrasound-guided cholangiography using microbubbles to evaluate the dilated biliary tract: initial experience. Eur Radiol 2012; 22: 371-378
    CrossrefPubMedSearch in Google Scholar
  • 217 Girlich C, Buttner R, Schacherer D. et al. Contrast-enhanced sonographic drainage control: a feasibility study. Z Gastroenterol 2011; 49: 1470-1474
    Thieme ConnectPubMedSearch in Google Scholar
  • 218 Muller T, Blank W, Leitlein J. et al. Endocavitary contrast-enhanced ultrasound: a technique whose time has come?. J Clin Ultrasound 2015; 43: 71-80
    CrossrefPubMedSearch in Google Scholar
  • 219 Lencioni R, Crocetti L. Local-regional treatment of hepatocellular carcinoma. Radiology 2012; 262: 43-58
    CrossrefPubMedSearch in Google Scholar
  • 220 Liu F, Yu X, Liang P. et al. Ultrasonography-guided percutaneous microwave ablation for large hepatic cavernous haemangiomas. Int J Hyperthermia 2018; 34: 1061-1066
    CrossrefPubMedSearch in Google Scholar
  • 221 Francica G, Meloni MF, Riccardi L. et al. Ablation treatment of primary and secondary liver tumors under contrast-enhanced ultrasound guidance in field practice of interventional ultrasound centers. A multicenter study. Eur J Radiol 2018; 105: 96-101
    CrossrefPubMedSearch in Google Scholar
  • 222 Liu F, Yu X, Liang P. et al. Contrast-enhanced ultrasound-guided microwave ablation for hepatocellular carcinoma inconspicuous on conventional ultrasound. Int J Hyperthermia 2011; 27: 555-562
    CrossrefPubMedSearch in Google Scholar
  • 223 Chan AK, Hegarty C, Klass D. et al. The Role of Contrast-enhanced Ultrasound in Guiding Radiofrequency Ablation of Hepatocellular Carcinoma: A Retrospective Study. Can Assoc Radiol J 2015; 66: 171-178
    CrossrefPubMedSearch in Google Scholar
  • 224 Bo XW, Xu HX, Wang D. et al. Fusion imaging of contrast-enhanced ultrasound and contrast-enhanced CT or MRI before radiofrequency ablation for liver cancers. Br J Radiol 2016; 89: 20160379
    CrossrefPubMedSearch in Google Scholar
  • 225 Xu E, Long Y, Li K. et al. Comparison of CT/MRI-CEUS and US-CEUS fusion imaging techniques in the assessment of the thermal ablation of liver tumors. Int J Hyperthermia 2019; 35: 159-167
    CrossrefPubMedSearch in Google Scholar
  • 226 Meloni MF, Andreano A, Franza E. et al. Contrast enhanced ultrasound: Should it play a role in immediate evaluation of liver tumors following thermal ablation?. Eur J Radiol 2012; 81: e897-e902
    CrossrefPubMedSearch in Google Scholar
  • 227 Mauri G, Porazzi E, Cova L. et al. Intraprocedural contrast-enhanced ultrasound (CEUS) in liver percutaneous radiofrequency ablation: clinical impact and health technology assessment. Insights Imaging 2014; 5: 209-216
    CrossrefPubMedSearch in Google Scholar
  • 228 Numata K, Fukuda H, Morimoto M. et al. Use of fusion imaging combining contrast-enhanced ultrasonography with a perflubutane-based contrast agent and contrast-enhanced computed tomography for the evaluation of percutaneous radiofrequency ablation of hypervascular hepatocellular carcinoma. Eur J Radiol 2012; 81: 2746-2753
    CrossrefPubMedSearch in Google Scholar
  • 229 Zhong-Zhen S, Kai L, Rong-Qin Z. et al. A feasibility study for determining ablative margin with 3D-CEUS-CT/MR image fusion after radiofrequency ablation of hepatocellular carcinoma. Ultraschall in Med 2012; 33: E250-E255
    Thieme ConnectPubMedSearch in Google Scholar
  • 230 Makino Y, Imai Y, Igura T. et al. Feasibility of Extracted-Overlay Fusion Imaging for Intraoperative Treatment Evaluation of Radiofrequency Ablation for Hepatocellular Carcinoma. Liver Cancer 2016; 5: 269-279
    CrossrefPubMedSearch in Google Scholar
  • 231 Li K, Su ZZ, Xu EJ. et al. Improvement of ablative margins by the intraoperative use of CEUS-CT/MR image fusion in hepatocellular carcinoma. BMC Cancer 2016; 16: 277
    CrossrefPubMedSearch in Google Scholar
  • 232 Ye J, Huang G, Zhang X. et al. Three-dimensional contrast-enhanced ultrasound fusion imaging predicts local tumor progression by evaluating ablative margin of radiofrequency ablation for hepatocellular carcinoma: a preliminary report. Int J Hyperthermia 2019; 36: 55-64
    CrossrefPubMedSearch in Google Scholar
  • 233 Minami Y, Kudo M, Chung H. et al. Contrast harmonic sonography-guided radiofrequency ablation therapy versus B-mode sonography in hepatocellular carcinoma: prospective randomized controlled trial. Am J Roentgenol 2007; 188: 489-494
    CrossrefPubMedSearch in Google Scholar
  • 234 Lencioni R, Llovet JM. Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis 2010; 30: 52-60
    Thieme ConnectPubMedSearch in Google Scholar
  • 235 Choi D, Lim HK, Lee WJ. et al. Early assessment of the therapeutic response to radio frequency ablation for hepatocellular carcinoma: utility of gray scale harmonic ultrasonography with a microbubble contrast agent. J Ultrasound Med 2003; 22: 1163-1172
    CrossrefPubMedSearch in Google Scholar
  • 236 Zheng SG, Xu HX, Lu MD. et al. Role of contrast-enhanced ultrasound in follow-up assessment after ablation for hepatocellular carcinoma. World J Gastroenterol 2013; 19: 855-865
    CrossrefPubMedSearch in Google Scholar
  • 237 Kisaka Y, Hirooka M, Kumagi T. et al. Usefulness of contrast-enhanced ultrasonography with abdominal virtual ultrasonography in assessing therapeutic response in hepatocellular carcinoma treated with radiofrequency ablation. Liver Int 2006; 26: 1241-1247
    CrossrefPubMedSearch in Google Scholar
  • 238 Qu P, Yu X, Liang P. et al. Contrast-enhanced ultrasound in the characterization of hepatocellular carcinomas treated by ablation: comparison with contrast-enhanced magnetic resonance imaging. Ultrasound Med Biol 2013; 39: 1571-1579
    CrossrefPubMedSearch in Google Scholar
  • 239 Frieser M, Kiesel J, Lindner A. et al. Efficacy of contrast-enhanced US versus CT or MRI for the therapeutic control of percutaneous radiofrequency ablation in the case of hepatic malignancies. Ultraschall in Med 2011; 32: 148-153
    Thieme ConnectPubMedSearch in Google Scholar
  • 240 Chen MH, Yang W, Yan K. et al. Large liver tumors: protocol for radiofrequency ablation and its clinical application in 110 patients--mathematic model, overlapping mode, and electrode placement process. Radiology 2004; 232: 260-271
    CrossrefPubMedSearch in Google Scholar
  • 241 Ferrara N, Kerbel RS. Angiogenesis as a therapeutic target. Nature 2005; 438: 967-974
    CrossrefPubMedSearch in Google Scholar
  • 242 Kessler T, Bayer M, Schwoppe C. et al. Compounds in clinical Phase III and beyond. Recent Results Cancer Res 2010; 180: 137-163
    CrossrefPubMedSearch in Google Scholar
  • 243 Dietrich CF, Averkiou MA, Correas JM. et al. An EFSUMB introduction into Dynamic Contrast-Enhanced Ultrasound (DCE-US) for quantification of tumour perfusion. Ultraschall in Med 2012; 33: 344-351
    Thieme ConnectPubMedSearch in Google Scholar
  • 244 Bos LJ, Piek JJ, Spaan JA. Background subtraction from time-intensity curves in videodensitometry: a pitfall in flow assessment using contrast echocardiography. Ultrasound Med Biol 1995; 21: 1211-1218
    CrossrefPubMedSearch in Google Scholar
  • 245 Peronneau P, Lassau N, Leguerney I. et al. Contrast ultrasonography: necessity of linear data processing for the quantification of tumor vascularization. Ultraschall in Med 2010; 31: 370-378
    Thieme ConnectPubMedSearch in Google Scholar
  • 246 Cosgrove D, Lassau N. Imaging of perfusion using ultrasound. Eur J Nucl Med Mol Imaging 2010; 37 (Suppl. 01) S65-S85
    CrossrefPubMedSearch in Google Scholar
  • 247 Therasse P, Arbuck SG, Eisenhauer EA. et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000; 92: 205-216
    CrossrefPubMedSearch in Google Scholar
  • 248 World Health Organisation. WHO handbook for reporting results of cancer treatment. Geneva, Switzerland. 1979 WHO Offset Publication. No. 48. Available at: https://apps.who.int/iris/handle/10665/37200 Accessed on June 1, 2019.
    PubMedSearch in Google Scholar
  • 249 De Giorgi U, Aliberti C, Benea G. et al. Effect of angiosonography to monitor response during imatinib treatment in patients with metastatic gastrointestinal stromal tumors. Clin Cancer Res 2005; 11: 6171-6176
    CrossrefPubMedSearch in Google Scholar
  • 250 Lassau N, Chami L, Chebil M. et al. Dynamic contrast-enhanced ultrasonography (DCE-US) and anti-angiogenic treatments. Discov Med 2011; 11: 18-24
    PubMedSearch in Google Scholar
  • 251 Lassau N, Chami L, Koscielny S. et al. Quantitative functional imaging by Dynamic Contrast Enhanced Ultrasonography (DCE-US) in GIST patients treated with masatinib. Invest New Drugs 2012; 30: 765-771
    CrossrefPubMedSearch in Google Scholar
  • 252 Lassau N, Koscielny S, Chami L. et al. Advanced Hepatocellular Carcinoma: Early Evaluation of Response to Bevacizumab Therapy at Dynamic Contrast-enhanced US with Quantification--Preliminary Results. Radiology 2010; 258: 291-300
    CrossrefPubMedSearch in Google Scholar
  • 253 Lassau N, Lamuraglia M, Chami L. et al. Gastrointestinal stromal tumors treated with imatinib: monitoring response with contrast-enhanced sonography. Am J Roentgenol 2006; 187: 1267-1273
    CrossrefPubMedSearch in Google Scholar
  • 254 Frampas E, Lassau N, Zappa M. et al. Advanced Hepatocellular Carcinoma: early evaluation of response to targeted therapy and prognostic value of Perfusion CT and Dynamic Contrast Enhanced-Ultrasound. Preliminary results. Eur J Radiol 2013; 82: e205-e211
    CrossrefPubMedSearch in Google Scholar
  • 255 Lazar V, Lassau N, Meurice G. et al. Sorafenib plus dacarbazine in solid tumors: a phase I study with dynamic contrast-enhanced ultrasonography and genomic analysis of sequential tumor biopsy samples. Invest New Drugs 2014; 32: 312-322
    CrossrefPubMedSearch in Google Scholar
  • 256 Lo GM, Al Zahrani H, Jang HJ. et al. Detection of Early Tumor Response to Axitinib in Advanced Hepatocellular Carcinoma by Dynamic Contrast Enhanced Ultrasound. Ultrasound Med Biol 2016; 42: 1303-1311
    CrossrefPubMedSearch in Google Scholar
  • 257 Lassau N, Coiffier B, Faivre L. et al. Study of Intrapatient Variability and Reproducibility of Quantitative Tumor Perfusion Parameters Evaluated With Dynamic Contrast-Enhanced Ultrasonography. Invest Radiol 2017; 52: 148-154
    CrossrefPubMedSearch in Google Scholar
  • 258 Wu Z, Yang X, Chen L. et al. Anti-angiogenic therapy with contrast-enhanced ultrasound in colorectal cancer patients with liver metastasis. Medicine (Baltimore) 2017; 96: e6731
    CrossrefPubMedSearch in Google Scholar
  • 259 Hudson JM, Bailey C, Atri M. et al. The prognostic and predictive value of vascular response parameters measured by dynamic contrast-enhanced-CT, -MRI and -US in patients with metastatic renal cell carcinoma receiving sunitinib. Eur Radiol 2018; 28: 2281-2290
    CrossrefPubMedSearch in Google Scholar
  • 260 Hudson JM, Williams R, Tremblay-Darveau C. et al. Dynamic contrast enhanced ultrasound for therapy monitoring. Eur J Radiol 2015; 84: 1650-1657
    CrossrefPubMedSearch in Google Scholar
  • 261 Lencioni R. European Federation of Societies for Ultrasound in M, Biology. Impact of European Federation of Societies for Ultrasound in Medicine and Biology (EFSUMB) guidelines on the use of contrast agents in liver ultrasound. Eur Radiol 2006; 16: 1610-1613
    CrossrefPubMedSearch in Google Scholar
  • 262 Seitz K. EFSUMB-guidelines for CEUS are directive and effective. Ultraschall in Med 2010; 31: 225-227
    Thieme ConnectPubMedSearch in Google Scholar
  • 263 Lassau N, Bonastre J, Kind M. et al Validation of Dynamic Contrast-Enhanced Ultrasound in Predicting Outcomes of Antiangiogenic Therapy for Solid Tumors: The French Multicenter Support for Innovative and Expensive Techniques Study. Invest Radiol 2014; 49 (12) 794-800
    CrossrefPubMedSearch in Google Scholar
  • 264 O’Connor JP, Aboagye EO, Adams JE. et al. Imaging biomarker roadmap for cancer studies. Nat Rev Clin Oncol 2017; 14: 169-186
    CrossrefPubMedSearch in Google Scholar
  • 265 Jacob J, Deganello A, Sellars ME. et al. Contrast enhanced ultrasound (CEUS) characterization of grey-scale sonographic indeterminate focal liver lesions in pediatric practice. Ultraschall in Med 2013; 34: 529-540
    Thieme ConnectPubMedSearch in Google Scholar
  • 266 Fang C, Bernardo S, Sellars ME. et al. Contrast-enhanced ultrasound in the diagnosis of pediatric focal nodular hyperplasia and hepatic adenoma: interobserver reliability. Pediatr Radiol 2019; 49: 82-90
    CrossrefPubMedSearch in Google Scholar
  • 267 Menichini G, Sessa B, Trinci M. et al. Accuracy of contrast-enhanced ultrasound (CEUS) in the identification and characterization of traumatic solid organ lesions in children: a retrospective comparison with baseline US and CE-MDCT. Radiol Med 2015; 120: 989-1001
    CrossrefPubMedSearch in Google Scholar
  • 268 Durkin N, Deganello A, Sellars ME. et al. Post-traumatic liver and splenic pseudoaneurysms in children: Diagnosis, management, and follow-up screening using contrast enhanced ultrasound (CEUS). J Pediatr Surg 2016; 51: 289-292
    CrossrefPubMedSearch in Google Scholar
  • 269 Valentino M, Serra C, Pavlica P. et al. Blunt abdominal trauma: diagnostic performance of contrast-enhanced US in children--initial experience. Radiology 2008; 246: 903-909
    CrossrefPubMedSearch in Google Scholar
  • 270 Bonini G, Pezzotta G, Morzenti C. et al. Contrast-enhanced ultrasound with SonoVue in the evaluation of postoperative complications in pediatric liver transplant recipients. J Ultrasound 2007; 10: 99-106
    CrossrefPubMedSearch in Google Scholar
  • 271 Torres A, Koskinen SK, Gjertsen H. et al. Contrast-Enhanced Ultrasound for identifying circulatory complications after liver transplants in children. Pediatr Transplant 2019; 23: e13327
    CrossrefPubMedSearch in Google Scholar
  • 272 Rennert J, Dornia C, Georgieva M. et al. Identification of early complications following liver transplantation using contrast enhanced ultrasound (CEUS). First results. J Gastrointestin Liver Dis 2012; 21: 407-412
    PubMedSearch in Google Scholar
  • 273 Piskunowicz M, Kosiak W, Batko T. et al. Safety of intravenous application of second-generation ultrasound contrast agent in children: prospective analysis. Ultrasound Med Biol 2015; 41: 1095-1099
    CrossrefPubMedSearch in Google Scholar
  • 274 Yusuf GT, Sellars ME, Deganello A. et al. Retrospective Analysis of the Safety and Cost Implications of Pediatric Contrast-Enhanced Ultrasound at a Single Center. Am J Roentgenol 2017; 208: 446-452
    CrossrefPubMedSearch in Google Scholar
  • 275 American Institute of Ultrasound in Medicine. AIUM Practice Parameter for Documentation of an Ultrasound Examination. J Ultrasound Med 2020; 39: E1-E4
    CrossrefPubMedSearch in Google Scholar
  • 276 Piscaglia F, Nolsoe C, Dietrich CF. et al. The EFSUMB Guidelines and Recommendations on the Clinical Practice of Contrast Enhanced Ultrasound (CEUS): update 2011 on non-hepatic applications. Ultraschall in Med 2012; 33: 33-59
    Thieme ConnectPubMedSearch in Google Scholar
  • 277 Stenman C, Jamil S, Thorelius L. et al. Do radiologists agree on findings in radiographer-acquired sonographic examinations?. J Ultrasound Med 2013; 32: 513-518
    CrossrefPubMedSearch in Google Scholar
  • 278 Gilja OH. Report Education and Professional Standard Committee. In EFSUMB Newsletter. Ultraschall in Med 2009; 30: 86-87
    Thieme ConnectPubMedSearch in Google Scholar
  • 279 Dietrich CF, Ignee A, Greis C. et al Artifacts and pitfalls in contrast-enhanced ultrasound of the liver. Ultraschall in Med 2014; 35: 108-125 ; quiz 126–107
    Thieme ConnectPubMedSearch in Google Scholar
  • 280 Dietrich CF, Ignee A, Hocke M. et al. Pitfalls and artefacts using contrast enhanced ultrasound. Z Gastroenterol 2011; 49: 350-356
    Thieme ConnectPubMedSearch in Google Scholar
  • 281 Fetzer DT, Rafailidis V, Peterson C. et al. Artifacts in contrast-enhanced ultrasound: a pictorial essay. Abdom Radiol (NY) 2018; 43: 977-997
    CrossrefPubMedSearch in Google Scholar
  • 282 Cui XW, Ignee A, Hocke M. et al. Prolonged heterogeneous liver enhancement on contrast-enhanced ultrasound. Ultraschall in Med 2014; 35: 246-252
    Thieme ConnectPubMedSearch in Google Scholar